Starting HIV-infected patients on antiretroviral therapy reduces food insecurity and improves physical health, thereby contributing to the disruption of a lethal syndemic, UCSF and Massachusetts General Hospital researchers have found in a study focused on sub-Saharan Africa.
July 24, 2012
Population-wide levels of HIV virus dropped substantially between 2011 and May 2012 in a rural part of southwestern Uganda, the site of two community health campaigns led by doctors at the University of California, San Francisco (UCSF), San Francisco General Hospital and Trauma Center (SFGH) and Makerere University in Kampala, Uganda.
July 23, 2012
A clinical study in a remote region of southwest Uganda has demonstrated the feasibility of using a health campaign to rapidly test a community for HIV and simultaneously offer prevention and diagnosis for a variety of other diseases in rural and resource-poor settings of sub-Saharan Africa.
July 23, 2012
In January 2012, the U.S. Food and Drug Administration (FDA) issued new guidelines on dosing of an HIV medication used to treat people infected with both HIV and tuberculosis (TB) because of a potential interaction between two of the main drugs used to treat each disease.
July 21, 2012
Researchers from the University of California, San Francisco (UCSF) and Makerere University in Uganda have used hair and blood samples from three-month old infants born to HIV-positive mothers to measure the uninfected babies’ exposure — both in the womb and from breast-feeding — to antiretroviral medications their mothers were taking. The results, they said, are surprising.
July 11, 2011
An international team led by researchers from UCSF and the nonprofit Vaccine and Gene Therapy Institute of Port St. Lucie, Fla., has received a major grant from the National Institutes of Health to develop a strategy to eradicate HIV from the body.
December 07, 2010
David Vlahov, PhD, RN, a pioneer in urban health research, expert in global health epidemiology and highly prolific author, has been appointed the new dean of the UCSF School of Nursing, one of the nation’s preeminent graduate schools.
May 12, 2010
Understanding the processes underlying the diminishing life span of HIV patients, even though they are responding well to anti-retroviral therapy, will be the focus of a daylong symposium on May 18.